[go: up one dir, main page]

CN111956612A - Oxytetracycline spray and preparation method thereof - Google Patents

Oxytetracycline spray and preparation method thereof Download PDF

Info

Publication number
CN111956612A
CN111956612A CN202010819861.8A CN202010819861A CN111956612A CN 111956612 A CN111956612 A CN 111956612A CN 202010819861 A CN202010819861 A CN 202010819861A CN 111956612 A CN111956612 A CN 111956612A
Authority
CN
China
Prior art keywords
oxytetracycline
spray
add
mix
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010819861.8A
Other languages
Chinese (zh)
Inventor
魏占勇
宋婷婷
刘静
刘欣
魏丽娟
李金明
贾兴
耿智霞
瞿红颖
郭李珉
李红园
王德功
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Yuanzheng Pharmaceutical Co ltd
Original Assignee
Hebei Yuanzheng Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Yuanzheng Pharmaceutical Co ltd filed Critical Hebei Yuanzheng Pharmaceutical Co ltd
Priority to CN202010819861.8A priority Critical patent/CN111956612A/en
Publication of CN111956612A publication Critical patent/CN111956612A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明属于兽用医药领域,提供一种土霉素喷雾剂及其制备方法。本发明每1000g,包括主要成分20‑300g、络合剂10‑500g、有机溶剂200‑900g、保湿剂10‑100g、成膜剂10g‑200g、pH调节剂5‑100g、着色剂0.05‑50g,余量为纯化水;所述主要成分选自土霉素和盐酸土霉素的一种或两种。本发明喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,能够有效、方便治疗动物外伤,该制剂为外用药,喷在动物体表,无兽药残留,无休药期。The invention belongs to the field of veterinary medicine and provides an oxytetracycline spray and a preparation method thereof. Every 1000g of the present invention includes 20-300g of main components, 10-500g of complexing agent, 200-900g of organic solvent, 10-100g of moisturizing agent, 10-200g of film-forming agent, 5-100g of pH adjusting agent, and 0.05-50g of colorant , the remainder is purified water; the main component is selected from one or both of oxytetracycline and oxytetracycline hydrochloride. The medicine sprayed by the invention is evenly dispersed and stable, safe to use, can be administered multiple times, has low packaging cost, and can effectively and conveniently treat animal trauma. drug period.

Description

一种土霉素喷雾剂及其制备方法A kind of oxytetracycline spray and preparation method thereof

技术领域technical field

本发明属于兽用医药领域,具体涉及一种土霉素喷雾剂及其制备方法。The invention belongs to the field of veterinary medicine, in particular to an oxytetracycline spray and a preparation method thereof.

背景技术Background technique

土霉素属于四环素类广谱抗生素,对葡萄球菌、溶血性链球菌、炭疽杆菌、破伤风梭菌和梭状芽胞杆菌等革兰氏阳性菌作用较强,对大肠埃希菌、沙门氏菌、布鲁氏菌和巴氏杆菌等革兰氏阴性菌较敏感。本品对立克次体、衣原体、支原体、螺旋体、放线菌和某些原虫也有抑制作用。Oxytetracycline belongs to tetracycline broad-spectrum antibiotics, and has strong effect on gram-positive bacteria such as Staphylococcus, hemolytic streptococcus, Bacillus anthracis, Clostridium tetani and Clostridium spp. Gram-negative bacteria such as L. brucei and Pasteurella are more susceptible. This product also has inhibitory effects on rickettsia, chlamydia, mycoplasma, spirochetes, actinomycetes and some protozoa.

动物外伤,特别是腐蹄病,最为常见,因养殖环境条件差往往引起细菌感染,经久不愈,土霉素为广谱抗生素,对动物外伤有很好的治疗。在兽医上土霉素及盐酸土霉素广泛用于口服和注射,但目前还没有土霉素喷雾剂及其制备方法。Animal trauma, especially hoof rot, is the most common. Bacterial infection is often caused by poor breeding environment, which will not heal for a long time. Oxytetracycline is a broad-spectrum antibiotic, which has a good treatment for animal trauma. In veterinary medicine, oxytetracycline and oxytetracycline hydrochloride are widely used for oral administration and injection, but there is no oxytetracycline spray and its preparation method.

发明内容SUMMARY OF THE INVENTION

本发明为了解决上述现有技术中存在的问题,提供了一种土霉素喷雾剂及其制备方法,喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,能够有效、方便治疗动物外伤,该制剂为外用药,喷在动物体表,无兽药残留,无休药期。In order to solve the above-mentioned problems in the prior art, the present invention provides an oxytetracycline spray and a preparation method thereof. The sprayed medicine is uniform and stable, safe to use, can be administered multiple times, has low packaging cost, and can It is effective and convenient for the treatment of animal trauma. The preparation is an external drug, sprayed on the surface of the animal body, and has no veterinary drug residue and no drug withdrawal period.

本发明采用的具体技术方案是:一种土霉素喷雾剂,关键是,每1000g,包括主要成分20-300g、络合剂10-500g、有机溶剂200-900g、保湿剂10-100g、成膜剂10g-200g、pH调节剂5-100g、着色剂0.05-50g,余量为纯化水;The specific technical scheme adopted in the present invention is: an oxytetracycline spray, the key is that every 1000g includes 20-300g of main components, 10-500g of complexing agent, 200-900g of organic solvent, 10-100g of moisturizing agent, 10g-200g of film agent, 5-100g of pH adjuster, 0.05-50g of colorant, and the balance is purified water;

所述主要成分选自土霉素和盐酸土霉素的一种或两种。The main component is selected from one or both of oxytetracycline and oxytetracycline hydrochloride.

优选地,所述有机溶剂选自甲醇、乙醇、异丙醇、二甲基甲酰胺、二甲基乙酰胺、2-吡咯烷酮和甲基吡咯烷酮的一种或至少两种。Preferably, the organic solvent is selected from one or at least two of methanol, ethanol, isopropanol, dimethylformamide, dimethylacetamide, 2-pyrrolidone and methylpyrrolidone.

优选地,所述络合剂选自氧化镁、氯化镁、氢氧化镁、碳酸镁中的一种或至少两种。Preferably, the complexing agent is selected from one or at least two of magnesium oxide, magnesium chloride, magnesium hydroxide, and magnesium carbonate.

优选地,所述保湿剂选自丙二醇、甘油、聚乙二醇中的一种或至少两种。Preferably, the humectant is selected from one or at least two of propylene glycol, glycerin, and polyethylene glycol.

优选地,所述的成膜剂为聚维酮K12、聚维酮K17和聚维酮K30的一种或至少两种。Preferably, the film-forming agent is one or at least two of povidone K12, povidone K17 and povidone K30.

优选地,所述的pH调节剂为盐酸、乳酸、氢氧化钠、乙醇胺、二乙醇胺、三乙醇胺和柠檬酸钠中的一种或至少两种。Preferably, the pH adjusting agent is one or at least two selected from hydrochloric acid, lactic acid, sodium hydroxide, ethanolamine, diethanolamine, triethanolamine and sodium citrate.

优选地,所述的着色剂为亮蓝、专利蓝、蓝色、胭脂色、甲紫和葡萄紫中的一种或至少两种。Preferably, the colorant is one or at least two selected from brilliant blue, patent blue, blue, carmine, nail violet and grape violet.

一种土霉素喷雾剂的制备方法,关键是,包括以下步骤:A kind of preparation method of oxytetracycline spray, the key is, comprises the following steps:

A、将络合剂加入70g~120g纯化水中混匀得到原液;A. The complexing agent is added into 70g~120g purified water and mixed to obtain a stock solution;

B、在原液中加入有机溶剂、保湿剂混匀;B. Add organic solvent and humectant to the original solution and mix well;

C、在步骤B得到的溶液中加入成膜剂混匀至溶解;C, in the solution obtained in step B, add film-forming agent and mix to dissolve;

D、在步骤C得到的溶液中加入盐酸土霉素或土霉素混匀至溶解D, in the solution obtained in step C, add oxytetracycline hydrochloride or oxytetracycline and mix until dissolved

E、在步骤D得到的溶液中加入PH调节剂调节pH为8.0~9.0;E, in the solution that step D obtains, add pH regulator to adjust pH to be 8.0~9.0;

F、在步骤E得到的溶液中加入着色剂,加入纯化水至1000g,混匀至溶解,过滤,灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add a colorant to the solution obtained in step E, add purified water to 1000 g, mix to dissolve, filter, and fill in a special bottle for spray to obtain the oxytetracycline spray.

优选地,所述的喷雾剂专用瓶中为带有喷雾装置的塑料瓶或带有喷雾装置的玻璃瓶。Preferably, the dedicated spray bottle is a plastic bottle with a spray device or a glass bottle with a spray device.

本发明的有益效果是:本发明制得的土霉素喷雾剂喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,用于治疗由多种细菌引起的动物外伤,缩短了疼痛和康复的时间,减轻了患病动物的痛苦。The beneficial effects of the invention are as follows: the oxytetracycline spray prepared by the invention has the advantages of uniform dispersion and stability, safe use, multiple administration, low packaging cost, and is used for treating animal trauma caused by various bacteria , shortens the time of pain and recovery, and relieves the suffering of sick animals.

具体实施方式Detailed ways

下面结合具体实施例对本发明作进一步说明:Below in conjunction with specific embodiment, the present invention will be further described:

实施例1Example 1

处方prescription

Figure BDA0002634079270000031
Figure BDA0002634079270000031

过程process

A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;

B、在原液中加入异丙醇、丙二醇混匀;B. Add isopropanol and propylene glycol to the stock solution and mix;

C、再加入聚维酮K17混匀至溶解;C, then add povidone K17 and mix to dissolve;

D、再加入盐酸土霉素混匀至溶解;D. Add oxytetracycline hydrochloride and mix until dissolved;

E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;

F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.

实施例2Example 2

处方prescription

Figure BDA0002634079270000032
Figure BDA0002634079270000032

Figure BDA0002634079270000041
Figure BDA0002634079270000041

过程process

A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;

B、在原液中加入乙醇、丙二醇混匀;B. Add ethanol and propylene glycol to the stock solution and mix;

C、再加入聚维酮K17混匀至溶解;C, then add povidone K17 and mix to dissolve;

D、再加入盐酸土霉素混匀至溶解;D. Add oxytetracycline hydrochloride and mix until dissolved;

E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;

F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.

实施例3Example 3

处方prescription

Figure BDA0002634079270000042
Figure BDA0002634079270000042

过程process

A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;

B、在原液中加入二甲基乙酰胺、丙二醇混匀;B. Add dimethylacetamide and propylene glycol to the stock solution and mix;

C、再加入聚维酮K12混匀至溶解;C, then add povidone K12 and mix to dissolve;

D、再加入土霉素混匀至溶解;D. Add oxytetracycline and mix until dissolved;

E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;

F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.

实施例4Example 4

处方prescription

Figure BDA0002634079270000051
Figure BDA0002634079270000051

过程process

A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;

B、在原液中加入甲基吡咯烷酮、丙二醇混匀;B. Add methylpyrrolidone and propylene glycol to the stock solution and mix;

C、再加入聚维酮K30混匀至溶解;C, then add Povidone K30 and mix to dissolve;

D、再加入土霉素混匀至溶解;D. Add oxytetracycline and mix until dissolved;

E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;

F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.

试验例1Test Example 1

将实施例3制备的土霉素喷雾剂分为3批,进行稳定性试验观察,包括影响因素试验(高温、光照)、加速试验(温度40±2℃,RH75±5%)6个月和长期试验(25±2℃,RH60±10%)24个月,试验条件、考察时间及考察项目如表1所示,试验结果见表1-4:The oxytetracycline spray prepared in Example 3 was divided into 3 batches, and the stability test was observed, including the influence factor test (high temperature, light), accelerated test (temperature 40±2°C, RH75±5%) for 6 months and Long-term test (25±2℃, RH60±10%) for 24 months, test conditions, inspection time and inspection items are shown in Table 1, and test results are shown in Table 1-4:

表1:土霉素喷雾剂稳定性试验内容及考察项目Table 1: Contents and investigation items of stability test of oxytetracycline spray

Figure BDA0002634079270000061
Figure BDA0002634079270000061

表2影响因素试验结果Table 2 Test results of influencing factors

Figure BDA0002634079270000062
Figure BDA0002634079270000062

表3加速试验结果Table 3 Accelerated test results

Figure BDA0002634079270000063
Figure BDA0002634079270000063

Figure BDA0002634079270000071
Figure BDA0002634079270000071

表4长期试验结果Table 4 Long-term test results

Figure BDA0002634079270000072
Figure BDA0002634079270000072

由表格可知,本发明制得的土霉素喷雾剂稳定性好,保质期长,能在较高的温度下保存,见光不易分解,耐光照。As can be seen from the table, the oxytetracycline spray prepared by the present invention has good stability, long shelf life, can be stored at a relatively high temperature, is not easily decomposed when exposed to light, and is resistant to light.

试验例2Test Example 2

按照实施例3制备的土霉素喷雾剂对牛、羊、猪腐蹄病效果观察,选择:土霉素喷雾剂(实施例3制备的批号为20190401);10%硫酸铜溶液+涂擦消炎膏(传统疗法);碘富(双链季铵盐络合碘、镇痛新)对患病动物用药。Observation of the effect of the oxytetracycline spray prepared in Example 3 on cattle, sheep, and pig foot rot, selection: oxytetracycline spray (the batch number prepared in Example 3 is 20190401); 10% copper sulfate solution + rubbing anti-inflammatory Ointment (traditional therapy); iodine-rich (double-chain quaternary ammonium salt complexed with iodine, analgesic new) are administered to sick animals.

试验方法:选择正常饲养过程中出现典型腐蹄病的牛60头,分为I、II、III、IV组,每组15头;羊80头,分为I、II、III、IV组,每组20头,猪120头,分为I、II、III、IV组,每组30头,给药方式为外用喷射,具体试验分组及给药情况见表5Test method: Select 60 cattle with typical hoof rot disease in the normal feeding process and divide them into I, II, III, IV groups, 15 heads in each group; 80 sheep, divided into I, II, III, IV groups, each There were 20 pigs in the group and 120 pigs, divided into I, II, III, IV groups, 30 pigs in each group, and the administration method was external spray.

表5试验分组及给药情况Table 5 Test grouping and administration

Figure BDA0002634079270000081
Figure BDA0002634079270000081

临床疗效判断标准:Criteria for judging clinical efficacy:

治愈:用药3天后试验动物食欲、体温、精神状态恢复正常,站立时病蹄完全着地,正常保持负重状态,无痛感,蹄趾外皮肤正常,无糜烂、肿胀特征,蹄趾间腐肉增生现象完全消失,停药一周内不复发。Cure: After 3 days of medication, the appetite, body temperature and mental state of the test animals returned to normal, the diseased hoof completely touched the ground when standing, the normal weight-bearing state was maintained, there was no pain, the outer skin of the hoof and toes was normal, there was no erosion or swelling, and the phenomenon of carrion between the hoof and toes was complete. Disappeared, no recurrence within a week of drug withdrawal.

有效:用药3天后试验动物食欲、体温、精神状态好转,站立时病蹄可以着地,基本保持负重状态,稍有痛感,蹄趾外皮肤明显好转,糜烂、肿胀未完全消失,蹄趾间腐肉增生现象明显好转,在停药观察期内症状不再加重。Effective: After 3 days of medication, the appetite, body temperature and mental state of the test animals improved, the diseased hoof could land on the ground when standing, and the weight-bearing state was basically maintained, with a slight pain, the skin outside the hoof and toes was obviously improved, the erosion and swelling did not completely disappear, and the slough between the hoof and toes was proliferated. The phenomenon improved significantly, and the symptoms no longer aggravated during the observation period of drug withdrawal.

无效:用药3天后试验动物食欲、体温、精神状态无改善甚至继续恶化,或在停药观察期内复发。Ineffective: The appetite, body temperature and mental state of the test animals did not improve or even continued to deteriorate after 3 days of treatment, or recurred during the observation period of drug withdrawal.

表6土霉素喷雾剂对牛腐蹄病的治疗效果Table 6 The therapeutic effect of oxytetracycline spray on cattle foot rot

分组grouping 病例数Number of cases 治愈(头)heal (head) 治愈率(%)Cure rate (%) 有效率(%)Efficient(%) 无效率(%)no efficiency(%) I组Group I 1515 1515 100100 100100 00 II组Group II 1515 1010 66.766.7 100100 00 III组Group III 1515 1212 80.080.0 100100 00 IV组Group IV 1515 00 00 00 100100

表7土霉素喷雾剂对羊腐蹄病的治疗效果Table 7 The therapeutic effect of oxytetracycline spray on sheep foot rot

分组grouping 病例数Number of cases 治愈(头)heal (head) 治愈率(%)Cure rate (%) 有效率(%)Efficient(%) 无效率(%)no efficiency(%) I组Group I 2020 2020 100100 100100 00 II组Group II 2020 1313 65.065.0 100100 00 III组Group III 2020 1616 80.080.0 100100 00 IV组Group IV 2020 00 00 00 100100

表8土霉素喷雾剂对猪腐蹄病的治疗效果Table 8 The therapeutic effect of oxytetracycline spray on pig foot rot

分组grouping 病例数Number of cases 治愈(头)heal (head) 治愈率(%)Cure rate (%) 有效率(%)Efficient(%) 无效率(%)no efficiency(%) I组Group I 3030 3030 100100 100100 00 II组Group II 3030 24twenty four 80.080.0 100100 00 III组Group III 3030 2626 86.786.7 100100 00 IV组Group IV 3030 00 00 00 100100

从表6、7、8可知,土霉素喷雾剂可明显缓解患病动物的各种临床症状,提高治疗效果,优于10%硫酸铜溶液+涂擦消炎膏(传统疗法)、碘富(双链季铵盐络合碘、镇痛新),说明土霉素喷雾剂可以有效治疗患病动物的外伤,尤其是对腐蹄病起到一定的治疗作用,给药方式为外用喷雾,使用前摇动,喷数次直到病变完全被覆盖,使用安全,可多次给药,处理过的患畜在返回牧场前应在干燥的地面上站立一小时。As can be seen from Tables 6, 7 and 8, oxytetracycline spray can obviously relieve various clinical symptoms of sick animals and improve the therapeutic effect, which is better than 10% copper sulfate solution + Tumo anti-inflammatory cream (traditional therapy), iodine rich ( Double-chain quaternary ammonium salt complexed with iodine, analgesic new), indicating that oxytetracycline spray can effectively treat the trauma of sick animals, especially to play a certain therapeutic effect on foot rot. Shake and spray several times until the lesions are completely covered. It is safe to use and can be administered multiple times. Treated animals should stand on dry ground for one hour before returning to pasture.

Claims (9)

1.一种土霉素喷雾剂,其特征在于,每1000g,包括主要成分20-300g、络合剂10-500g、有机溶剂200-900g、保湿剂10-100g、成膜剂10g-200g、pH调节剂5-100g、着色剂0.05-50g,余量为纯化水;1. an oxytetracycline spray, is characterized in that, every 1000g, comprises main component 20-300g, complexing agent 10-500g, organic solvent 200-900g, moisturizing agent 10-100g, film-forming agent 10g-200g, pH adjuster 5-100g, colorant 0.05-50g, and the balance is purified water; 所述主要成分选自土霉素和盐酸土霉素的一种或两种。The main component is selected from one or both of oxytetracycline and oxytetracycline hydrochloride. 2.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述有机溶剂选自甲醇、乙醇、异丙醇、二甲基甲酰胺、二甲基乙酰胺、2-吡咯烷酮和甲基吡咯烷酮的一种或至少两种。2. a kind of oxytetracycline spray according to claim 1 is characterized in that, described organic solvent is selected from methanol, ethanol, isopropanol, dimethylformamide, dimethylacetamide, 2-pyrrolidone and one or at least two of methylpyrrolidone. 3.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述络合剂选自氧化镁、氯化镁、氢氧化镁、碳酸镁中的一种或至少两种。3. a kind of oxytetracycline spray according to claim 1 is characterized in that, described complexing agent is selected from one or at least two in magnesium oxide, magnesium chloride, magnesium hydroxide, magnesium carbonate. 4.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述保湿剂选自丙二醇、甘油、聚乙二醇中的一种或至少两种。4. a kind of oxytetracycline spray according to claim 1, is characterized in that, described moisturizing agent is selected from one or at least two in propylene glycol, glycerol, polyethylene glycol. 5.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述的成膜剂为聚维酮K12、聚维酮K17和聚维酮K30的一种或至少两种。5. a kind of oxytetracycline spray according to claim 1 is characterized in that, described film-forming agent is one or at least two of povidone K12, povidone K17 and povidone K30. 6.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述的pH调节剂为盐酸、乳酸、氢氧化钠、乙醇胺、二乙醇胺、三乙醇胺和柠檬酸钠中的一种或至少两种。6. a kind of oxytetracycline spray according to claim 1, is characterized in that, described pH regulator is one in hydrochloric acid, lactic acid, sodium hydroxide, ethanolamine, diethanolamine, triethanolamine and sodium citrate one or at least two. 7.根据权利要求1所述的一种土霉素喷雾剂,其特征在于,所述的着色剂为亮蓝、专利蓝、蓝色、胭脂色、甲紫和葡萄紫中的一种或至少两种。7. a kind of oxytetracycline spray according to claim 1, is characterized in that, described colorant is a kind of or at least in bright blue, patent blue, blue, carmine, nail violet and grape violet two kinds. 8.根据权利要求1至7所述的任一一种土霉素喷雾剂的制备方法,其特征在于,包括以下步骤:8. the preparation method of any one oxytetracycline spray according to claim 1 to 7, is characterized in that, comprises the following steps: A、将络合剂加入70g~120g纯化水中混匀得到原液;A. The complexing agent is added into 70g~120g purified water and mixed to obtain a stock solution; B、在原液中加入有机溶剂、保湿剂混匀;B. Add organic solvent and humectant to the original solution and mix well; C、在步骤B得到的溶液中加入成膜剂混匀至溶解;C, in the solution obtained in step B, add film-forming agent and mix to dissolve; D、在步骤C得到的溶液中加入盐酸土霉素或土霉素混匀至溶解D, in the solution obtained in step C, add oxytetracycline hydrochloride or oxytetracycline and mix until dissolved E、在步骤D得到的溶液中加入PH调节剂调节pH为8.0~9.0;E, in the solution that step D obtains, add pH regulator to adjust pH to be 8.0~9.0; F、在步骤E得到的溶液中加入着色剂,加入纯化水至1000g,混匀至溶解,过滤,灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add a colorant to the solution obtained in step E, add purified water to 1000 g, mix to dissolve, filter, and fill in a special bottle for spray to obtain the oxytetracycline spray. 9.根据权利要求8所述的一种土霉素喷雾剂的制备方法,其特征在于,所述的喷雾剂专用瓶中为带有喷雾装置的塑料瓶或带有喷雾装置的玻璃瓶。9. the preparation method of a kind of oxytetracycline spray according to claim 8, is characterized in that, in described spray special bottle is the plastic bottle with spray device or the glass bottle with spray device.
CN202010819861.8A 2020-08-14 2020-08-14 Oxytetracycline spray and preparation method thereof Pending CN111956612A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010819861.8A CN111956612A (en) 2020-08-14 2020-08-14 Oxytetracycline spray and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010819861.8A CN111956612A (en) 2020-08-14 2020-08-14 Oxytetracycline spray and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111956612A true CN111956612A (en) 2020-11-20

Family

ID=73387716

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010819861.8A Pending CN111956612A (en) 2020-08-14 2020-08-14 Oxytetracycline spray and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111956612A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117695225A (en) * 2023-12-26 2024-03-15 石家庄石牧药业有限公司 Aureomycin spray and preparation method thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB835603A (en) * 1956-05-29 1960-05-25 Pfizer Improvements in or relating to oxytetracycline salt containing compositions
CN102614298A (en) * 2012-04-26 2012-08-01 肖连元 Scalding spray and preparation method thereof
CN104352506A (en) * 2014-10-13 2015-02-18 四川维尔康动物药业有限公司 Long-acting oxytetracycline injection for veterinary use and preparation technology thereof
US20160287614A1 (en) * 2013-11-20 2016-10-06 Lupin Limited Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
CN108653200A (en) * 2017-03-27 2018-10-16 辽宁天鹏生物科技有限公司 A kind of long-acting occrycetin injection and preparation method thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB835603A (en) * 1956-05-29 1960-05-25 Pfizer Improvements in or relating to oxytetracycline salt containing compositions
CN102614298A (en) * 2012-04-26 2012-08-01 肖连元 Scalding spray and preparation method thereof
US20160287614A1 (en) * 2013-11-20 2016-10-06 Lupin Limited Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic
CN104352506A (en) * 2014-10-13 2015-02-18 四川维尔康动物药业有限公司 Long-acting oxytetracycline injection for veterinary use and preparation technology thereof
CN108653200A (en) * 2017-03-27 2018-10-16 辽宁天鹏生物科技有限公司 A kind of long-acting occrycetin injection and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
M. HOLZHAUER等: "Comparing the curative efficacy of topical treatment with thiamphenicol and oxytetracycline on digital dermatitis lesions in dairy cattle", 《VETERINARY RECORD》, 12 May 2017 (2017-05-12), pages 1 - 4 *
国家药品监督管理局执业药师资格认证中心组织编写: "《药学专业知识 一》", 31 March 2020, 中国医药科技出版社, pages: 274 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117695225A (en) * 2023-12-26 2024-03-15 石家庄石牧药业有限公司 Aureomycin spray and preparation method thereof
CN117695225B (en) * 2023-12-26 2024-07-26 石家庄石牧药业有限公司 Aureomycin spray and preparation method thereof

Similar Documents

Publication Publication Date Title
CN102188422B (en) Compound florfenicol injection and preparation method and application thereof
Gisbert et al. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments
CN104323987B (en) Mequindox injection and preparation method thereof
EP1462101B1 (en) Drinkable preparation comprising ketoprofen and use thereof in the simultaneous treatment of a group of animals of respiratory diseases
CN102228462B (en) Method for preparing veterinary oxytetracycline-artemisinin injection and clinical application of veterinary oxytetracycline-artemisinin injection
CN111956612A (en) Oxytetracycline spray and preparation method thereof
CN112022809A (en) A kind of oxytetracycline aerosol and preparation method thereof
CN104586777B (en) Ceftiofur hydrochloride powder injection and its preparation method and application
CN115381771A (en) Tylosin injection and preparation method thereof
CN102614294B (en) Compound amoxicillin suspension injection and preparation method thereof
CN102755337B (en) Compound florfenicol injection and preparation method thereof
CN100534433C (en) Ceftiofur-containing powder injection for beast
CN101829129B (en) Veterinary compound gentamycin sulfate injection and preparation method thereof
CN103126982A (en) Novel veterinary medicament meglumine enrofloxacin injection and preparation method thereof
CN100536843C (en) Pharmaceutical composition for injection containing faropenem
CN105902499B (en) Enrofloxacin soluble powder and preparation method thereof
CN104856977A (en) Externally-used film coating agent for treating fungal infection type dermatosis attacking cattle and sheep
CN111568864B (en) Colistin sulfate soluble powder capable of improving solubility and preparation method and application thereof
CN101912405A (en) A kind of pharmaceutical composition for treating bovine endometritis
CN115645390A (en) Preparation of valnemulin organic acid salt veterinary drug and application of valnemulin organic acid salt veterinary drug in preparation of drugs for treating poultry air sacculitis and pig pleuropneumonia
KR20120099676A (en) Pharmaceutical compositions
CN101375859A (en) Compound composite medicament for preventing and treating iron-deficiency anemia and secondary infection of young stock
CN102743395B (en) Compound ofloxacin injecta and preparation method thereof
CN100515425C (en) A pharmaceutical composition for preventing and treating respiratory tract and digestive tract diseases of livestock and poultry
RU2799015C1 (en) Method of local treatment of hoof diseases in cattle based on a combination of active ingredients

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20201120